Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Related Articles by Review for PubMed (Select 21487327)

1.

Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.

van den Bergh MR, Spijkerman J, François N, Swinnen K, Borys D, Schuerman L, Veenhoven RH, Sanders EA.

Pediatr Infect Dis J. 2011 Sep;30(9):e170-8. doi: 10.1097/INF.0b013e31821a0614.

PMID:
21487327
2.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
3.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
4.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
5.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Dhillon S.

Drugs. 2010 May 28;70(8):1021-58. doi: 10.2165/11204830-000000000-00000. Review.

PMID:
20481658
6.

New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).

Johns TL, Hutter GE.

Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Review.

PMID:
20197476
7.

Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).

Dhillon S.

BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000. Review.

PMID:
20795752
8.

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

Prymula R, Schuerman L.

Expert Rev Vaccines. 2009 Nov;8(11):1479-500. doi: 10.1586/erv.09.113. Review.

PMID:
19863240
9.

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.

Baldo V, Bonanni P, Castro M, Gabutti G, Franco E, Marchetti F, Prato R, Vitale F.

Hum Vaccin Immunother. 2014;10(1):129-37. doi: 10.4161/hv.26269. Epub 2013 Sep 4. Review.

10.

Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).

Zepp F, Schmitt HJ, Cleerbout J, Verstraeten T, Schuerman L, Jacquet JM.

Expert Rev Vaccines. 2009 Jun;8(6):663-78. doi: 10.1586/erv.09.32. Review.

PMID:
19485747
11.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).

Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005530. doi: 10.1002/14651858.CD005530.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD005530.

PMID:
19588375
12.

Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience.

Reynolds DL, Vidor E.

Expert Rev Vaccines. 2014 Aug;13(8):943-68. doi: 10.1586/14760584.2014.933674. Epub 2014 Jul 2. Review.

PMID:
24985159
13.

10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

Plosker GL.

Paediatr Drugs. 2014 Oct;16(5):425-44. doi: 10.1007/s40272-014-0089-x. Review.

PMID:
25192686
14.

A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience.

Plotkin SA, Liese J, Madhi SA, Ortiz E.

Expert Rev Vaccines. 2011 Jul;10(7):981-1005. doi: 10.1586/erv.11.72. Epub 2011 Jul 12. Review.

PMID:
21749196
15.

Meningococcal groups C and Y and haemophilus B tetanus toxoid conjugate vaccine (HibMenCY-TT; MenHibrix(®)): a review.

Perry CM.

Drugs. 2013 May;73(7):703-13. doi: 10.1007/s40265-013-0048-9. Review.

PMID:
23649970
16.

The safety advantages of pentavalent vaccines.

Merchant N, Waldrop J.

Nurse Pract. 2012 Apr 15;37(4):48-53. doi: 10.1097/01.NPR.0000412895.12310.9d. Review.

PMID:
22430930
17.

Combination vaccines in the South African setting.

Visser A, Hoosen A.

Vaccine. 2012 Sep 7;30 Suppl 3:C38-44. doi: 10.1016/j.vaccine.2012.05.001. Review.

PMID:
22939020
18.
19.

The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9. doi: 10.1097/INF.0000000000000081. Review.

20.

Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa - successes and challenges.

Baleta AF, van den Heever J, Burnett RJ.

Vaccine. 2012 Sep 7;30 Suppl 3:C66-71. doi: 10.1016/j.vaccine.2012.06.033. Review.

PMID:
22939025
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk